Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Conditions
Interventions
Sirolimus
Locations
10
United States
801 University of California, San Francisco HIV/AIDS CRS
San Francisco, California, United States
Whitman Walker Health CRS (31791)
Washington D.C., District of Columbia, United States
Univ. of Miami AIDS CRS (901)
Miami, Florida, United States
The Ponce de Leon Center CRS (5802)
Atlanta, Georgia, United States
Washington University CRS (2101)
St Louis, Missouri, United States
Weill Cornell Uptown CRS (7803)
New York, New York, United States
Start Date
December 21, 2015
Primary Completion Date
November 2, 2017
Completion Date
February 1, 2018
Last Updated
August 3, 2021
NCT06660498
NCT06602622
NCT06185452
NCT06902038
NCT04568603
NCT01511809
Lead Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions